Logo image of STAA

STAAR SURGICAL CO (STAA) Stock Fundamental Analysis

NASDAQ:STAA - Nasdaq - US8523123052 - Common Stock - Currency: USD

23.95  +0.87 (+3.77%)

After market: 23.95 0 (0%)

Fundamental Rating

7

Taking everything into account, STAA scores 7 out of 10 in our fundamental rating. STAA was compared to 191 industry peers in the Health Care Equipment & Supplies industry. STAA gets an excellent profitability rating and is at the same time showing great financial health properties. STAA is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make STAA a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

STAA had positive earnings in the past year.
STAA had a positive operating cash flow in the past year.
STAA had positive earnings in each of the past 5 years.
In the past 5 years STAA always reported a positive cash flow from operatings.
STAA Yearly Net Income VS EBIT VS OCF VS FCFSTAA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M 40M

1.2 Ratios

STAA's Return On Assets of 4.05% is fine compared to the rest of the industry. STAA outperforms 78.95% of its industry peers.
The Return On Equity of STAA (5.09%) is better than 77.37% of its industry peers.
STAA's Return On Invested Capital of 4.05% is fine compared to the rest of the industry. STAA outperforms 75.26% of its industry peers.
STAA had an Average Return On Invested Capital over the past 3 years of 7.40%. This is in line with the industry average of 8.08%.
Industry RankSector Rank
ROA 4.05%
ROE 5.09%
ROIC 4.05%
ROA(3y)6.93%
ROA(5y)5.97%
ROE(3y)8.89%
ROE(5y)7.69%
ROIC(3y)7.4%
ROIC(5y)5.91%
STAA Yearly ROA, ROE, ROICSTAA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20 -30

1.3 Margins

The Profit Margin of STAA (6.38%) is better than 77.89% of its industry peers.
In the last couple of years the Profit Margin of STAA has grown nicely.
The Operating Margin of STAA (7.53%) is better than 75.26% of its industry peers.
STAA's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 78.73%, STAA belongs to the top of the industry, outperforming 91.58% of the companies in the same industry.
STAA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.53%
PM (TTM) 6.38%
GM 78.73%
OM growth 3Y27.96%
OM growth 5Y10.36%
PM growth 3Y22.42%
PM growth 5Y10.43%
GM growth 3Y2.67%
GM growth 5Y1.21%
STAA Yearly Profit, Operating, Gross MarginsSTAA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so STAA is destroying value.
STAA has more shares outstanding than it did 1 year ago.
STAA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for STAA has been reduced compared to a year ago.
STAA Yearly Shares OutstandingSTAA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
STAA Yearly Total Debt VS Total AssetsSTAA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 7.68 indicates that STAA is not in any danger for bankruptcy at the moment.
STAA has a Altman-Z score of 7.68. This is amongst the best in the industry. STAA outperforms 84.74% of its industry peers.
There is no outstanding debt for STAA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.68
ROIC/WACC0.44
WACC9.24%
STAA Yearly LT Debt VS Equity VS FCFSTAA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

STAA has a Current Ratio of 5.99. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
STAA has a better Current ratio (5.99) than 82.63% of its industry peers.
A Quick Ratio of 5.38 indicates that STAA has no problem at all paying its short term obligations.
STAA has a Quick ratio of 5.38. This is amongst the best in the industry. STAA outperforms 83.68% of its industry peers.
Industry RankSector Rank
Current Ratio 5.99
Quick Ratio 5.38
STAA Yearly Current Assets VS Current LiabilitesSTAA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.71% over the past year.
The Earnings Per Share has been growing by 43.10% on average over the past years. This is a very strong growth
The Revenue has grown by 10.00% in the past year. This is quite good.
Measured over the past years, STAA shows a very strong growth in Revenue. The Revenue has been growing by 21.06% on average per year.
EPS 1Y (TTM)62.71%
EPS 3Y71%
EPS 5Y43.1%
EPS Q2Q%26.67%
Revenue 1Y (TTM)10%
Revenue growth 3Y25.4%
Revenue growth 5Y21.06%
Sales Q2Q%10.31%

3.2 Future

STAA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.86% yearly.
Based on estimates for the next years, STAA will show a quite strong growth in Revenue. The Revenue will grow by 14.26% on average per year.
EPS Next Y22.97%
EPS Next 2Y16.79%
EPS Next 3Y23.39%
EPS Next 5Y28.86%
Revenue Next Year6.35%
Revenue Next 2Y8.43%
Revenue Next 3Y10.08%
Revenue Next 5Y14.26%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
STAA Yearly Revenue VS EstimatesSTAA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
STAA Yearly EPS VS EstimatesSTAA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 1 1.5 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.95 indicates a rather expensive valuation of STAA.
Based on the Price/Earnings ratio, STAA is valued cheaper than 85.26% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.64. STAA is around the same levels.
STAA is valuated quite expensively with a Price/Forward Earnings ratio of 29.26.
Based on the Price/Forward Earnings ratio, STAA is valued a bit cheaper than the industry average as 75.26% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of STAA to the average of the S&P500 Index (24.51), we can say STAA is valued inline with the index average.
Industry RankSector Rank
PE 24.95
Fwd PE 29.26
STAA Price Earnings VS Forward Price EarningsSTAA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of STAA indicates a somewhat cheap valuation: STAA is cheaper than 75.79% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, STAA is valued a bit cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 44.88
EV/EBITDA 26.39
STAA Per share dataSTAA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of STAA may justify a higher PE ratio.
A more expensive valuation may be justified as STAA's earnings are expected to grow with 23.39% in the coming years.
PEG (NY)1.09
PEG (5Y)0.58
EPS Next 2Y16.79%
EPS Next 3Y23.39%

More info and screens

0

5. Dividend

5.1 Amount

STAA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STAAR SURGICAL CO

NASDAQ:STAA (1/23/2025, 4:30:01 PM)

After market: 23.95 0 (0%)

23.95

+0.87 (+3.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners93.48%
Inst Owner Change-0.63%
Ins Owners0.51%
Ins Owner Change0.81%
Market Cap1.18B
Analysts79
Price Target43.19 (80.33%)
Short Float %7.22%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.99%
Min EPS beat(2)47.54%
Max EPS beat(2)120.44%
EPS beat(4)3
Avg EPS beat(4)55.01%
Min EPS beat(4)-26.79%
Max EPS beat(4)120.44%
EPS beat(8)6
Avg EPS beat(8)58.64%
EPS beat(12)9
Avg EPS beat(12)58.96%
EPS beat(16)13
Avg EPS beat(16)176%
Revenue beat(2)1
Avg Revenue beat(2)0.95%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.96%
Revenue beat(4)2
Avg Revenue beat(4)0.25%
Min Revenue beat(4)-1.46%
Max Revenue beat(4)1.96%
Revenue beat(8)3
Avg Revenue beat(8)0.28%
Revenue beat(12)4
Avg Revenue beat(12)0.05%
Revenue beat(16)7
Avg Revenue beat(16)1.96%
PT rev (1m)-1.48%
PT rev (3m)-14.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-103.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.36%
Valuation
Industry RankSector Rank
PE 24.95
Fwd PE 29.26
P/S 3.46
P/FCF 44.88
P/OCF 25.08
P/B 2.76
P/tB 2.77
EV/EBITDA 26.39
EPS(TTM)0.96
EY4.01%
EPS(NY)0.82
Fwd EY3.42%
FCF(TTM)0.53
FCFY2.23%
OCF(TTM)0.95
OCFY3.99%
SpS6.92
BVpS8.69
TBVpS8.65
PEG (NY)1.09
PEG (5Y)0.58
Profitability
Industry RankSector Rank
ROA 4.05%
ROE 5.09%
ROCE 5.45%
ROIC 4.05%
ROICexc 8.11%
ROICexgc 8.17%
OM 7.53%
PM (TTM) 6.38%
GM 78.73%
FCFM 7.71%
ROA(3y)6.93%
ROA(5y)5.97%
ROE(3y)8.89%
ROE(5y)7.69%
ROIC(3y)7.4%
ROIC(5y)5.91%
ROICexc(3y)19.04%
ROICexc(5y)16.2%
ROICexgc(3y)19.35%
ROICexgc(5y)16.56%
ROCE(3y)9.97%
ROCE(5y)7.99%
ROICexcg growth 3Y8.98%
ROICexcg growth 5Y-4.52%
ROICexc growth 3Y9.85%
ROICexc growth 5Y-3.69%
OM growth 3Y27.96%
OM growth 5Y10.36%
PM growth 3Y22.42%
PM growth 5Y10.43%
GM growth 3Y2.67%
GM growth 5Y1.21%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 362.25%
Cap/Sales 6.08%
Interest Coverage 250
Cash Conversion 149.7%
Profit Quality 120.78%
Current Ratio 5.99
Quick Ratio 5.38
Altman-Z 7.68
F-Score5
WACC9.24%
ROIC/WACC0.44
Cap/Depr(3y)377.17%
Cap/Depr(5y)335.52%
Cap/Sales(3y)5.98%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.71%
EPS 3Y71%
EPS 5Y43.1%
EPS Q2Q%26.67%
EPS Next Y22.97%
EPS Next 2Y16.79%
EPS Next 3Y23.39%
EPS Next 5Y28.86%
Revenue 1Y (TTM)10%
Revenue growth 3Y25.4%
Revenue growth 5Y21.06%
Sales Q2Q%10.31%
Revenue Next Year6.35%
Revenue Next 2Y8.43%
Revenue Next 3Y10.08%
Revenue Next 5Y14.26%
EBIT growth 1Y37.75%
EBIT growth 3Y60.47%
EBIT growth 5Y33.61%
EBIT Next Year87.95%
EBIT Next 3Y52.08%
EBIT Next 5Y48.17%
FCF growth 1Y16.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.08%
OCF growth 3Y-11.35%
OCF growth 5Y2.71%